137 related articles for article (PubMed ID: 34334379)
21. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.
Huang Q; Wang C; Hou Z; Wang G; Lv J; Wang H; Yang J; Zhang Z; Zhang H
Cancer Biomark; 2017; 19(2):137-144. PubMed ID: 28211798
[TBL] [Abstract][Full Text] [Related]
24. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
25. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
26. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
[TBL] [Abstract][Full Text] [Related]
27. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
Gao F; Wang Y; Li H; Yin J
Technol Health Care; 2024 May; ():. PubMed ID: 38848201
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
29. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of serum miR-25 in non-small-cell lung cancer.
Li J; Yu M; Liu Z; Liu B
Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
[No Abstract] [Full Text] [Related]
33. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
34. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
Sun B; Liu HF; Ding Y; Li Z
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
[TBL] [Abstract][Full Text] [Related]
36. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
Farzanehpour M; Mozhgani SH; Jalilvand S; Faghihloo E; Akhavan S; Salimi V; Azad TM
Virol J; 2019 Oct; 16(1):116. PubMed ID: 31590680
[TBL] [Abstract][Full Text] [Related]
37. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
39. miR-21 and miR29-a: Potential Molecular Biomarkers for HPV Genotypes and Cervical Cancer Detection.
Zamani S; Hosseini SM; Sohrabi A
Microrna; 2020; 9(4):271-275. PubMed ID: 31733640
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
